Event

Hot Topic Discussion: Impact of Injectable PrEP on Donor Testing and Screening (22EL-766) – Free for AABB Individual Members!

Please note: AABB reserves the right to make updates to this program.

Thursday August 18, 2022
2:00 PM - 3:15 PM Eastern Time
Program Number: 22EL-766

Registration

AshlandThis Hot Topic Discussion is provided complimentary to AABB individual members through the generous support of Ashland, an AABB Premium Corporate Partner; nonmembers to pay regular eCast rate of $69. Group viewing/registration is not provided. Registration is required and includes access to both the live and on-demand version of this hot topic discussion.

Within 48-72 hours after registering, you will receive an email with access instructions to join the live program that will be unique to you (please make sure to check your junk or spam email folders). Access instructions will be sent to the email address you used when registering for this program (please take a moment to click on the “Add to Calendar” link to add it to your calendar).

Please note: Registration for the live program will close 1 hour prior to the start time. If you register after this time, you will receive access to the on-demand program when it is available.

If you would like to receive this program for free as well as other great benefits, consider joining AABB today.

  • Program Description

    This program will provide new information regarding the potential impact of donor use of long-acting, injectable cabotegravir as pre-exposure prophylaxis (PrEP) approved by FDA in late December 2021, and new considerations for donor testing and screening. Expert speakers will provide brief presentations, followed by a question and discussion period.

    Faculty

    Moderator: Sharon Carayiannis, MT(ASCP)HP, Vice President, Science and Practice, Association for the Advancement of Blood & Biotherapies (AABB)
    Speakers:

    • Jed B. Gorlin, MD, MBA, Vice President and Medical Director, Innovative Blood Resources; Chair, AABB Transfusion Transmitted Diseases Committee
    • Brian Custer, PhD, MPH, Director, Vitalant Research Institute; Senior Vice President, Research and Scientific Programs, Vitalant; Adjunct Professor, Department of Laboratory Medicine, University of California San Francisco
    • Mary Townsend, MD, Senior Medical Director, National Office, Vitalant; Chair, AABB Donor History Task Force

    Continuing Education Credit

    AABB estimates both the live and on-demand version of this program each to be eligible for 1.25 continuing education credits/contact hours for California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage. Please note: California Nurse and continuing education credits for physicians are not available for this program.

    Disclosures for the program faculty are provided at the beginning of the program.

     

    Register